Immunovant

IMVT | NASDAQ | 0 Obserwujący

$18.13

+3.60%

$0.63

Obserwuj

Overview Metrics Financials

Fair Price

$43.35

Overvalued by 42.3%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Immunovant, Inc. is an American biotechnology company focused on the development of innovative immunotherapies for the treatment of autoimmune diseases. The company specializes in the development of monoclonal antibodies that target specific immune pathways, which can help patients suffering from conditions such as myasthenia gravis, autoimmune hemolytic anemia, and others. Immunovant aims to provide effective therapeutic options for patients whose current treatments are insufficient or associated with undesirable side effects.

Feed

There are no posts to show right now.

Immunovant

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?